Over 23.3 mn balance vax doses available with states, pvt hospitals: Centre

More than 2.33 crore balance and unutilised COVID-19 vaccine doses are still available with the states, union territories and private hospitals, the Union Health Ministry said on Monday

Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner, Sunday, Aug. 8, 2021. (PTI Photo)
Visitors wait to get their dose of Covid-19 vaccine at an inoculation centre in Bikaner, Sunday, Aug. 8, 2021. (PTI Photo)
Press Trust of India New Delhi
2 min read Last Updated : Aug 09 2021 | 3:28 PM IST

More than 2.33 crore balance and unutilised COVID-19 vaccine doses are still available with the states, union territories and private hospitals, the Union Health Ministry said on Monday.

More than 52.40 crore vaccine doses have been provided to states and UTs so far through all sources, and a further 8,39,780 doses are in the pipeline, it said.

Of this, the total consumption, including wastage, is 50,51,29,252 doses (as per data available at 8 am on Monday), the ministry said.

More than 2.33 crore balance and unutilised COVID-19 vaccine doses are still available with the states, UTs and private hospitals to be administered, it added.

The Union government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country, the ministry said.

The new phase of universalisation of COVID-19 vaccination commenced from 21st June, 2021.

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to states and UTs for enabling better planning by them, and streamlining the vaccine supply chain, the ministry said.

As part of the nationwide vaccination drive, the government of India has been supporting the states and UTs by providing them COVID-19 vaccines free of cost.

In the new phase of the universalisation of the COVID-19 vaccination drive, the Union government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the manufacturers in the country to the states and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccination

First Published: Aug 09 2021 | 2:14 PM IST

Next Story